| Patent Number |
Title Of Patent |
Date Issued |
| 7553931 |
Complement depletion using recombinant human C3-derivatives |
June 30, 2009 |
| The invention provides isolated polypeptides having complement-modulating activity. Specifically, the invention resides in the provision of isolated polypeptides having complement-depleting properties, i.e. that effect an efficient consumption of complement in human serum. The current |
| 7208077 |
Sensor arrangement with electrically controllable arrays |
April 24, 2007 |
| An electric sensor array which is provided with several sensor positions that each have at least two microelectrodes. Molecular substances can be detected electrochemically and charged molecules can be transported or handled using the array. Measuring procedures can be effected, especial |
| 6881379 |
Method for producing detection systems with planar arrays |
April 19, 2005 |
| The invention relates to a method for producing a detection system for detecting different analytes in a sample, characterised by the following steps: providing a planar or essentially planar substrate which has sensors for chemically, optically or electrically detecting the analytes; |
| 6607897 |
Recombinant proCVF |
August 19, 2003 |
| Recombinant proCVF exhibits substantially the same activity as CVF and is useful for lowering complement activity. |
| 6303754 |
Recombinant procvf |
October 16, 2001 |
| Recombinant proCVF exhibits substantially the same activity as CVF and is useful for lowering complement activity |
| 5965106 |
In vivo binding pair pretargeting |
October 12, 1999 |
| A method for in-vivo targeting a functional moiety in a patient by administering a targeting moiety coupled to an affinity component, wherein the targeting moiety has affinity for binding sites in a target area, and administering a binding partner to the affinity component coupled to a |
| 5922320 |
Recombinant proCVF |
July 13, 1999 |
| Recombinant proCVF exhibits substantially the same activity as CVF and is useful for lowering complement activity. |
| 5807534 |
In vivo binding pair pretargeting |
September 15, 1998 |
| A method for in-vivo targeting a functional moiety in a patient by administering a targeting moiety coupled to an affinity component, wherein the targeting moiety has affinity for binding sites in a target area, and administering a binding partner to the affinity component coupled to a |
| 5773243 |
Cobra pro CVF1 |
June 30, 1998 |
| DNA sequences encoding cobra C3, CVF1, and CVF2, as well as plasmids and transformed hosts comprising such DNA sequences, are provided. |
| 5714344 |
Protease-derivatized CVF |
February 3, 1998 |
| A novel functionally active derivative of cobra venom factor is described in which the .beta.-chain has been cleaved by treatment with a protease. Gel electrophoretic analyses of the purified derivative revealed the absence of an intact .beta.-chain and a decrease of the molecular weight |
| 5705634 |
High yield preparation of dimeric to decameric chitin oligomers |
January 6, 1998 |
| The present invention is directed to a new process for the production of chitin oligomers, including fragmentation, partial hydrolysis and recovery. This process produces high yields, especially of higher (tetra- to deca-) chitin oligomers. |
| 5578289 |
In vivo binding pair pretargeting |
November 26, 1996 |
| A method for in-vivo targeting a functional moiety in a patient by administering a targeting moiety coupled to an affinity component, wherein the targeting moiety has affinity for binding sites in a target area, and administering a binding partner to the affinity component coupled to a |
